In a historic ruling, a judge in Michigan decided on August 8th that the Public Readiness and Emergency Preparedness (PREP) Act does not shield a drug manufacturer and a hospital in the case of a man who suffered two strokes and had to undergo a leg amputation due to receiving remdesivir, a COVID-19 medication that was contaminated with glass particles.
This marks the inaugural instance where a judge has determined that the PREP Act does not provide protection to a drug manufacturer or a...